Phase I trial of Vical's influenza virus DNA vaccine in volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2011
At a glance
- Drugs Influenza virus DNA vaccine (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 27 Apr 2011 Status changed from active, no longer recruiting to completed, according to information from a Vical media release.
- 17 Feb 2011 Results expected in the first quarter of 2011.
- 03 Aug 2010 Enrollment has been completed as reported by a Vical media release.